Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 4
2015 38
2016 69
2017 86
2018 73
2019 81
2020 12
Text availability
Article attribute
Article type
Publication date

Search Results

327 results
Results by year
Filters applied: . Clear all
Page 1
Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial.
Landovitz RJ, Li S, Grinsztejn B, Dawood H, Liu AY, Magnus M, Hosseinipour MC, Panchia R, Cottle L, Chau G, Richardson P, Marzinke MA, Hendrix CW, Eshleman SH, Zhang Y, Tolley E, Sugarman J, Kofron R, Adeyeye A, Burns D, Rinehart AR, Margolis D, Spreen WR, Cohen MS, McCauley M, Eron JJ. Landovitz RJ, et al. PLoS Med. 2018 Nov 8;15(11):e1002690. doi: 10.1371/journal.pmed.1002690. eCollection 2018 Nov. PLoS Med. 2018. PMID: 30408115 Free PMC article. Clinical Trial.
BACKGROUND: Cabotegravir (CAB) is a novel strand-transfer integrase inhibitor being developed for HIV treatment and prevention. ...The safety and pharmacokinetic results observed support the further development of CAB LA, and efficacy studies of CAB LA for HIV treatment
BACKGROUND: Cabotegravir (CAB) is a novel strand-transfer integrase inhibitor being developed for HIV treatment and prevention. ...Th …
Long-term retention in pre-exposure prophylaxis care among men who have sex with men and transgender women in the United States.
Chan PA, Patel RR, Mena L, Marshall BD, Rose J, Sutten Coats C, Montgomery MC, Tao J, Sosnowy C, Mayer KH, Nunn A. Chan PA, et al. J Int AIDS Soc. 2019 Aug;22(8):e25385. doi: 10.1002/jia2.25385. J Int AIDS Soc. 2019. PMID: 31423756 Free PMC article.
Self-reported adherence was strongly correlated with retention. In multivariable analyses, younger age was associated with decreased odds of retention at initial follow-up, and completing college was associated with increased odds of retention at 16 months. ...
Self-reported adherence was strongly correlated with retention. In multivariable analyses, younger age was associated with decreased …
Barriers and Facilitators of PrEP Adherence for Young Men and Transgender Women of Color.
Wood S, Gross R, Shea JA, Bauermeister JA, Franklin J, Petsis D, Swyryn M, Lalley-Chareczko L, Koenig HC, Dowshen N. Wood S, et al. AIDS Behav. 2019 Oct;23(10):2719-2729. doi: 10.1007/s10461-019-02502-y. AIDS Behav. 2019. PMID: 30993479 Clinical Trial.
Short-term and sustained adherence were measured by urine tenofovir concentration and pharmacy refills, respectively. Optimal adherence was defined as having both urine tenofovir concentration consistent with dose ingestion within 48 h and pharmacy refills consisten …
Short-term and sustained adherence were measured by urine tenofovir concentration and pharmacy refills, respectively. Optimal adhe
Syndemic factors associated with adherence to antiretroviral therapy among HIV-positive adult heterosexual men.
McMahon JM, Braksmajer A, Zhang C, Leblanc N, Chen M, Aidala A, Simmons J. McMahon JM, et al. AIDS Res Ther. 2019 Nov 9;16(1):32. doi: 10.1186/s12981-019-0248-9. AIDS Res Ther. 2019. PMID: 31706357 Free PMC article.
BACKGROUND: Suboptimal adherence to HIV antiretroviral therapy (ART) and concomitant lack of viral control can have severe consequences for health and onward transmission among persons living with HIV. Little is known about the barriers and facilitators of optimal ART a
BACKGROUND: Suboptimal adherence to HIV antiretroviral therapy (ART) and concomitant lack of viral control can have severe consequenc …
Impact of HIV Infection on the Clinical Presentation and Survival of Non-Hodgkin Lymphoma: A Prospective Observational Study From Botswana.
Milligan MG, Bigger E, Abramson JS, Sohani AR, Zola M, Kayembe MKA, Medhin H, Suneja G, Lockman S, Chabner BA, Dryden-Peterson SL. Milligan MG, et al. J Glob Oncol. 2018 Sep;4:1-11. doi: 10.1200/JGO.17.00084. J Glob Oncol. 2018. PMID: 30241264 Free PMC article.
Currently, there are few data regarding the sociodemographic factors, clinical characteristics, and outcomes of non-Hodgkin lymphoma (NHL)-an AIDS-defining cancer-in the country. ...Treatment patterns and clinical outcomes were analyzed. RESULTS: One hundred four pa …
Currently, there are few data regarding the sociodemographic factors, clinical characteristics, and outcomes of non-Hodgkin lymphoma (NHL)-a …
Improving HIV Care Engagement in the South from the Patient and Provider Perspective: The Role of Stigma, Social Support, and Shared Decision-Making.
Taylor BS, Fornos L, Tarbutton J, Muñoz J, Saber JA, Bullock D, Villarreal R, Nijhawan AE. Taylor BS, et al. AIDS Patient Care STDS. 2018 Sep;32(9):368-378. doi: 10.1089/apc.2018.0039. AIDS Patient Care STDS. 2018. PMID: 30179530 Free PMC article.
The study was conducted in two large majority/minority HIV treatment centers in the United States (US) south, a geographical region disproportionately impacted by HIV. ...Using Grounded Theory to frame analysis, we found similar perspectives for all groups, including belie …
The study was conducted in two large majority/minority HIV treatment centers in the United States (US) south, a geographical region d …
Acceptability and Barriers to HIV Pre-Exposure Prophylaxis in Atlanta's Adolescents and Their Parents.
Shah M, Gillespie S, Holt S, Morris CR, Camacho-Gonzalez AF. Shah M, et al. AIDS Patient Care STDS. 2019 Oct;33(10):425-433. doi: 10.1089/apc.2019.0109. Epub 2019 Aug 22. AIDS Patient Care STDS. 2019. PMID: 31436485
Two-sample hypothesis testing, Pearson correlations, and linear regression were used. Of the 102 adolescent/parent dyads, 67% of adolescents were female, 94% black, with a mean age of 15.7 ± 1.5 years, and 31% were sexually active. ...
Two-sample hypothesis testing, Pearson correlations, and linear regression were used. Of the 102 adolescent/parent dyads, 67% of adol …
Safety and Feasibility of Antiretroviral Preexposure Prophylaxis for Adolescent Men Who Have Sex With Men Aged 15 to 17 Years in the United States.
Hosek SG, Landovitz RJ, Kapogiannis B, Siberry GK, Rudy B, Rutledge B, Liu N, Harris DR, Mulligan K, Zimet G, Mayer KH, Anderson P, Kiser JJ, Lally M, Brothers J, Bojan K, Rooney J, Wilson CM. Hosek SG, et al. JAMA Pediatr. 2017 Nov 1;171(11):1063-1071. doi: 10.1001/jamapediatrics.2017.2007. JAMA Pediatr. 2017. PMID: 28873128 Free PMC article. Clinical Trial.
DESIGN, SETTING, AND PARTICIPANTS: Adolescent Medicine Trials Network for HIV/AIDS Interventions 113 (Project PrEPare) was a PrEP demonstration project that evaluated the safety, tolerability, and acceptability of TDF/FTC and patterns of use, rates of adherence, and …
DESIGN, SETTING, AND PARTICIPANTS: Adolescent Medicine Trials Network for HIV/AIDS Interventions 113 (Project PrEPare) was a PrEP dem …
327 results
Jump to page
Feedback